# RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows

> **NCT04577898** · NA · COMPLETED · sponsor: **Teoxane SA** · enrollment: 248 (actual)

## Conditions studied

- Infra-orbital Hollows
- Tear-trough Deformity
- Wrinkle

## Interventions

- **DEVICE:** RHA® Redensity Eye

## Key facts

- **NCT ID:** NCT04577898
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-02
- **Primary completion:** 2023-05-16
- **Final completion:** 2025-02-14
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04577898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04577898, "RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04577898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*